Buy PeptidesReference compendium

About / Peptides / Bremelanotide

Immunity

Bremelanotide

Chemical compound

  • FormulaC50H68N14O10
  • Molecular weight1025.2 g/mol
  • CAS number189691-06-3
  • PubMed results94

Reference sheet 5 of 40Data retrieved 2026-10-08.PubChem · PubMed · Wikipedia

Available in the shop

See the whole catalogue →

Sold for in vitro laboratory research only — not for human or animal consumption. ≥99% purity specification.

Identification

Field of researchImmunity
FormulaC50H68N14O10
Molecular weight1025.2 g/mol
CAS number189691-06-3
Also known asBremelanotida, 6Y24O4F92S, PT-141 FREE BASE, PT 141, Bremelanotidum, RefChem:58355, PT-141, Bremelanotide [USAN:INN], PT141, Vyleesi (TN)
PubChemCID 9941379

Summary

Bremelanotide, sold under the brand name Vyleesi, is a medication used to treat low sexual desire in women.

From Wikipedia, available under CC BY-SA 4.0. Short description from Wikidata (CC0).

Published research

Titles are shown as published. Listing a paper is not an endorsement of its findings, and many papers on research peptides are laboratory or animal studies: the type of study is shown when PubMed records it.

  1. BremelanotideReview2012 · PMID 34436837
  2. BremelanotideReview2006 · PMID 31369224
  3. Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and TreatmentReviewPettigrew JA, Novick AM · J Midwifery Womens Health, 2021 · PMID 34510696 · DOI
  4. Bremelanotide: First ApprovalReviewDhillon S, Keam SJ · Drugs, 2019 · PMID 31429064 · DOI
  5. Therapeutic peptides in gerontology: mechanisms and applications for healthy agingReviewMavrych V, Shypilova I, Bolgova O · Front Aging, 2026 · PMID 42021992 · DOI
  6. Safety Profile of Bremelanotide Across the Clinical Development ProgramClinical Trial, Phase IIIRandomized Controlled TrialResearch Support, Non-U.S. Gov'tClayton AH, Kingsberg SA, Portman D et al. · J Womens Health (Larchmt), 2022 · PMID 35147466 · DOI
  7. Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment OptionsSystematic ReviewMeta-AnalysisToledo RG, Winkelman WD, Reyes-Gonzalez D et al. · J Minim Invasive Gynecol, 2026 · PMID 40543759 · DOI
  8. Targeting the central melanocortin system for the treatment of metabolic disordersReviewResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tSweeney P, Gimenez LE, Hernandez CC et al. · Nat Rev Endocrinol, 2023 · PMID 37365323 · DOI

Top 8 of 94 results, by relevance. See all on PubMed.

Search query "Bremelanotide"[Title/Abstract]

Data provenance

DataSourceRecord
Chemical identity and structurePubChemCID 9941379
Published literaturePubMedSearch on PubMed
Summary sentenceWikipediaBremelanotide

Data retrieved 2026-10-08. See About for the sources. How the data is collected and checked: Methods.